Twitter Facebook-f Youtube Instagram

ROUTINE IMMUNISATION SCHEDULE FOR ALL AGES CHILDREN, ADOLESCENTS AND ADULTS | 2024

ANDALUSIA, SPAIN

Desplácese a través de la tabla
VACCINES
Pre
natal
0 months
2 months
4 months
6 months
11 months
12 months
15 months
3 years
4 years
6
years
12 years
13 years
14 years
15 years
18 years
60 years
65 years
73 years
+73 years
Tetanus,
diphteria,
pertussis
Tdap 1
DTaP
DTaP
DTaP
DTaP2
Td
Td3
Td
Td3
Poliomyelitis
IPV
IPV
IPV
IPV2
Hepatitis B
HepB 4
HepB
HepB
HepB
HepB 5
Haemophilus influenzae b
Hib
Hib
Hib
Pneumococcal Conjugate6
PCV13
PCV13
PCV13
PCV20
Meningococcal
B7
MenB
MenB
MenB
Meningococcal
ACWY
Men ACWY8
Men ACWY9
Men ACWY10
Men ACWY11
MMR
MMR
MMR
MMR 12
Varicella
VZV
VZV
VZV13
Papillomavirus
HPV14
HPV15
Influenza
Influenza 16
Annual Influenza 17
Annual Influenza 18
Shingles (Herpes zoster) 19
HZ
NOTES
ESPAÑOL
PDF

Routine vaccination

Catch-up vaccination for non-immunised people

Twitter Facebook-f Youtube Instagram

Leyenda

DTaP

Diphteria and Tetanus toxoids, and acellular Pertussis (whooping cough) vaccine for children.

Tdap

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (whooping cough) vaccine.

Td

Tetanus and diphtheria toxoids vaccine.

Tdap1

Pertussis vaccination during pregnancy: one Tdap vaccine dose during every pregnancy from 27 weeks gestation, but preferably at week 27 or 28.

DTaP2

DTaP-IPV routine vaccination at 6 years of age: from January 2023, 6-year-old children (born from January 1, 2017) will receive DTaP-IPV vaccination (Tetraxim®). Until then, children at 6 years will be given Tdap vaccination. Children born before 2017 without the Tdap dose at 6 years old, should receive a Tdap dose (Boostrix®).

Td3

Td vaccination in adults: check prior vaccination status before starting or completing a primary vaccination scheme with Td in adults. Health services, including occupational health and safety services, should be contacted to verify the vaccination status and, when required, Td vaccination will be administered until completing 5 doses. A Td dose will be administered to adults aged around 65 who received 5 doses during childhood and adolescence.

IPV

Inactivated Poliomyelitis Vaccine.

IPV2

DTaP-IPV routine vaccination at 6 years of age: from January 2023, 6-year-old children (born from January 1, 2017) will receive DTaP-IPV vaccination (Tetraxim®). Until then, children at 6 years will be given Tdap vaccination. Children born before 2017 without the Tdap dose at 6 years old, should receive a Tdap dose (Boostrix®).

HepB

Hepatitis B vaccine.

HepB 4

Monocomponent vaccine against HepB in newborns: babies born to mothers infected with hepatitis B (HBsAg+) will be given a first dose of the hepatitis B vaccine within 24 hours of their birth (preferably within 12 hours of birth), together with administration of anti-HBs immunoglobulin. Babies of mothers with unknown HBsAg, if tests results are not available within the first 24 hours of life, will also be given a dose of hepatitis B vaccine. All babies must follow the standard hexavalent vaccine scheme: doses given at 2, 4 and 11 months of age. Thus, babies born to mothers with HBsAg+, will be given 4-doses: at 0, 2, 4 and 11 months of age.

HepB 5

Monocomponent vaccine against HepB in children and adolescents: children and teenagers up to the age of 18, who have never been vaccinated before, will follow a 3-dose series at 0, 1 and 6 months.

Hib

Haemophilus influenzae type b vaccine.

PCV 6

Pneumococcal conjugate vaccine: (PCV13) for adults aged 60-72: routine vaccination is recommended with 13-valent pneumococcal conjugate vaccine (PCV13, Prevenar 13®) for infants at 2, 4 and 11 months of age, and with 20-valent pneumococcal conjugate vaccine (PCV20, Apexxnar®) for all adults born between 1951 and 1963 previously unvaccinated with PCV13 or PCV20

MenB

Meningococcal serogroup B vaccine.

MenB7

Vaccination against meningococcal B: for infants born after October 1st 2021.

MenC

Meningococcal serogroup C conjugate vaccine.

Men ACWY

Meningococcal conjugate vaccine against serogroups A, C, W and Y.

Men ACWY8

Vaccination against meningococcal ACWY at 12 years of age: A dose will be given to all 12-year-old teens (born in 2011) who did not receive a dose of MenACWY since the age of 10.

Men ACWY9

Meningococcal ACWY immunisation campaign to 13-21 year-olds: all teenagers born between 2002 and 2010 with no previous vaccination after 10 years old will be vaccinated with one dose.

MMR

Measles, Mumps and Rubella vaccine.

MMR10

Catch-up MMR vaccination: Health services, including occupational health and safety services, should be contacted to verify vaccination status. Vaccination is recommended in people age 4-65 years old with no history of previous vaccination nor history of measles. When required, two doses of MMR vaccine will be given with a minimum interval of 4 weeks between doses. If a first dose has been previously administered, only one MMR dose will be given. MMR vaccine is not suitable for pregnant women nor for people who are immunosuppressed.

VZV

Varicella Zoster Virus (chickenpox) vaccine.

VZV11

Catch-up vaccination against varicella (VZV) (chickenpox): Vaccination is recommended in people aged 4-65 years old who have never had chickenpox and have no history of complete VZV immunisation, should be given 2 doses with a minimum interval of 4 weeks (preferably 8 weeks). If a first dose has been previously administered, they will only be given one dose. Adults with no history of chickenpox and who have not been vaccinated will be tested for IgG antibodies. If there is a history of one documented dose given, the second dose will be given. VZV vaccine is not suitable for pregnant women nor for people who are immunosuppressed.

HPV

Human Papillomavirus Vaccine.

HPV12

Routine immunisation against the human papillomavirus (HPV) for boys and girls at 12 years of age: two doses will be given, with at least 12 months between them.

HPV13

Catch-up vaccination against human papillomavirus (HPV) to 13-18 years-old women: this immunisation is meant for 13 to 18-year-old girls, not vaccinated or partially vaccinated before. 2 or 3-dose scheme will be scheduled according to age of first dose given. 2-dose series will have a minimum interval of 12 months between doses; 3-dose series at 0, 2 and 6 months.

Influenza14

Flu vaccination during pregnancy: pregnant women may be vaccinated during the flu immunisation campaign at any stage of pregnancy, or during the first 6 months of the postpartum period.

Annual Influenza15

Flu vaccination for children aged 6-59 months: annually, in every flu immunisation campaign, all children should receive flu vaccination.

Annual Influenza16

Flu vaccination for adults 65 and over: annually, in every flu immunisation campaign, one-dose routine vaccination is recommended.